PubMed=9973934; DOI=10.1016/S0165-4608(98)00122-8
Mark A. Nelson, Maria E. Ariza, Jin-Ming Yang, Floyd H. Thompson, Raymond Taetle, Jeffrey M. Trent, Julie Wymer, Kathy S. Massey-Brown, Marianne Broome-Powell, John Easton, Jill M. Lahti, Vincent J. Kidd;
Abnormalities in the p34cdc2-related PITSLRE protein kinase gene complex (CDC2L) on chromosome band 1p36 in melanoma.
Cancer Genet. Cytogenet. 108:91-99(1999)

PubMed=10952317; DOI=10.1038/35020115
Michael Bittner, Paul S. Meltzer, Yi-Dong Chen, Yuan Jiang, Elisabeth A. Seftor, Mary J.C. Hendrix, Michael D. Radmacher, Richard M. Simon, Zohar Yakhini, Amir Ben-Dor, Nick Sampas ...Show all 28 authors... , Edward Russell Dougherty, Ena Wang, Francesco M. Marincola, Gerald C. Gooden, John Lueders, Arthur Glatfelter, Pamela M. Pollock, John D. Carpten, Elizabeth M. Gillanders, Darryl Leja, Kathleen Dietrich, Christian Beaudry, Michael E. Berens, David Samuel Alberts, Vernon K. Sondak, Nicholas K. Hayward, Jeffrey M. Trent; Show fewer authors
Molecular classification of cutaneous malignant melanoma by gene expression profiling.
Nature 406:536-540(2000)

PubMed=12115485; DOI=10.1002/ijc.10422
Yong-Mei Feng, Jia-Qi Shi, Alisa Miriam Goldstein, Margaret Anne Tucker, Mark A. Nelson;
Analysis of mutations and identification of several polymorphisms in the putative promoter region of the P34CDC2-related CDC2L1 gene located at 1P36 in melanoma cell lines and melanoma families.
Int. J. Cancer 99:834-838(2002)

PubMed=24879157; DOI=10.4161/auto.28594; PMCID=PMC4091172
Megan L. Goodall, Tong Wang, Katie R. Martin, Matthew G. Kortus, Audra L. Kauffman, Jeffrey M. Trent, Stephen Gately, Jeffrey P. MacKeigan;
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.
Autophagy 10:1120-1136(2014)